197 related articles for article (PubMed ID: 2879069)
41. Inotropic, chronotropic and dromotropic effects of prenalterol, a new cardiostimulant drug.
Moore EN; Aberg G; Spear JF; Hodess AB; Herrmann I; Adler G
Acta Med Scand Suppl; 1982; 659():53-70. PubMed ID: 6958179
[TBL] [Abstract][Full Text] [Related]
42. Noninvasive assessment of chronotropic and inotropic response to preferential beta-1 and beta-2 adrenoceptor stimulation.
Corea L; Bentivoglio M; Verdecchia P; Motolese M; Sorbini CA; Grassi V; Tantucci C
Clin Pharmacol Ther; 1984 Jun; 35(6):776-81. PubMed ID: 6145533
[TBL] [Abstract][Full Text] [Related]
43. Influence of adenosine on the stimulatory effect of isoprenaline and insulin on myocardial contractility in vivo.
Law WR; Carney PJ; McLane MP
Cardiovasc Res; 1991 Feb; 25(2):151-7. PubMed ID: 1742765
[TBL] [Abstract][Full Text] [Related]
44. The importance of the alpha-adrenoceptor agonist activity of dobutamine to inotropic selectivity in the anaesthetized cat.
Kenakin TP; Johnson SF
Eur J Pharmacol; 1985 May; 111(3):347-54. PubMed ID: 2990956
[TBL] [Abstract][Full Text] [Related]
45. Celiprolol: a positive inotropic beta-adrenoceptor blocking agent in conscious dogs.
Nganele DM; DeLeonardis VM; Hintze TH
Br J Pharmacol; 1988 Mar; 93(3):501-8. PubMed ID: 2897217
[TBL] [Abstract][Full Text] [Related]
46. A comparison of the properties of prenalterol and corwin at beta 1- and beta 2-adrenoreceptors in vitro.
Gurden JM; Apperley GH; Drew GM
J Auton Pharmacol; 1989 Apr; 9(2):79-91. PubMed ID: 2565903
[TBL] [Abstract][Full Text] [Related]
47. Regional myocardial contractile response to the beta-adrenergic stimulant prenalterol in the conscious dog following myocardial infarction. Mechanism of hemodynamic effect.
Kirlin PC; Romson JL; Pitt B; Lucchesi B
Pharmacology; 1984; 28(1):51-60. PubMed ID: 6701187
[TBL] [Abstract][Full Text] [Related]
48. The haemodynamic effects of intravenous prenalterol and ouabain in conscious dogs.
Ek L; Björkman JA; Carlsson E; Johansson B
Acta Med Scand Suppl; 1982; 659():39-52. PubMed ID: 6127899
[TBL] [Abstract][Full Text] [Related]
49. A comparison of the hemodynamic effects of prenalterol and isoprenaline in patients with complete heart block.
Svendsen TL; Pelle H; Lønholt C; Bonde J; Kampmann JP; Lindeneg O
J Cardiovasc Pharmacol; 1984; 6(4):693-6. PubMed ID: 6206327
[TBL] [Abstract][Full Text] [Related]
50. Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
Arnold JM; O'Connor PC; Riddell JG; Harron DW; Shanks RG; McDevitt DG
Br J Clin Pharmacol; 1985 May; 19(5):619-30. PubMed ID: 2860915
[TBL] [Abstract][Full Text] [Related]
51. Terbutaline-induced desensitization of human cardiac beta 2-adrenoceptor-mediated positive inotropic effects: attenuation by ketotifen.
Poller U; Fuchs B; Gorf A; Jakubetz J; Radke J; Pönicke K; Brodde OE
Cardiovasc Res; 1998 Oct; 40(1):211-22. PubMed ID: 9876334
[TBL] [Abstract][Full Text] [Related]
52. The action of creatinol 0-phosphate on the inotropic effect of isoprenaline in isolated rat atria and in anesthetized dogs.
Godfraind T; Ghysel-Burton J; Merlo L
Arzneimittelforschung; 1979; 29(9a):1465-7. PubMed ID: 575493
[TBL] [Abstract][Full Text] [Related]
53. Discrepancies between inotropic responses and beta-adrenoceptor characteristics after global ischemia in isolated hearts.
van den Ende R; Batink HD; Pfaffendorf M; van Zwieten PA
J Cardiovasc Pharmacol; 1991 Nov; 18(5):679-86. PubMed ID: 1723764
[TBL] [Abstract][Full Text] [Related]
54. Pharmacokinetic-pharmacodynamic modelling of S(-)-atenolol in rats: reduction of isoprenaline-induced tachycardia as a continuous pharmacodynamic endpoint.
van Steeg TJ; Freijer J; Danhof M; de Lange EC
Br J Pharmacol; 2007 Jun; 151(3):356-66. PubMed ID: 17420778
[TBL] [Abstract][Full Text] [Related]
55. Comparative effects of beta-adrenoceptor partial agonists on isolated rat atrium.
Vigholt-Sørensen E; Påby L; Halliday SE; Snow HM
Pharmacol Toxicol; 1991 Nov; 69(5):351-4. PubMed ID: 1687080
[TBL] [Abstract][Full Text] [Related]
56. [Reduction of isoprenaline induced tachycardia in pregnant rats. Role of a serum factor].
Auclair MC; Carli A; Lechat P; Leperlier M; Vernimmen C
C R Seances Acad Sci D; 1979 Jul; 289(2):205-8. PubMed ID: 117926
[TBL] [Abstract][Full Text] [Related]
57. The role of beta-adrenoceptors in coronary blood flow distribution in normal and ischemic canine myocardium.
Berdeaux A; Garnier M; Boissier JR; Giudicelli JF
Eur J Pharmacol; 1979 Jan; 53(3):261-71. PubMed ID: 215419
[TBL] [Abstract][Full Text] [Related]
58. [Central cardiovascular effect of isoprenaline and some adrenergic beta blocking agents in neurogenic hypertensive dog: role of central beta-adrenoceptors (author's transl)].
Montastruc P; Montastruc JL
J Physiol (Paris); 1978; 74(7):651-8. PubMed ID: 218002
[No Abstract] [Full Text] [Related]
59. Cardiovascular effects of beta 3-adrenoceptor stimulation in perinephritic hypertension.
Donckier JE; Massart PE; Van Mechelen H; Heyndrickx GR; Gauthier C; Balligand JL
Eur J Clin Invest; 2001 Aug; 31(8):681-9. PubMed ID: 11473569
[TBL] [Abstract][Full Text] [Related]
60. Drinking and antidiuresis elicited by isoprenaline in the dog.
Fitzsimons JT; Szczepańska-Sadowska E
J Physiol; 1974 Jun; 239(2):251-67. PubMed ID: 4412866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
